258 related articles for article (PubMed ID: 12478891)
1. [Inhibition of activator protein-1 on the growth of gastric cancer by octreotide].
Wang CH; Tang CW
Ai Zheng; 2002 Aug; 21(8):850-4. PubMed ID: 12478891
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of human gastric cancer metastasis by ocreotide in vitro and in vivo].
Wang C; Tang C
Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(1):19-22. PubMed ID: 11953120
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition effects of octreotide on the growth of hepatocellular carcinoma in vitro and in vivo].
Wang C; Tang C; Tang L
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1194-7. PubMed ID: 11769709
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition effect of aspirin on the growth of gastric cancer and the mechanism there-in involved].
Wang C; Tang C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):468-71. PubMed ID: 12910692
[TBL] [Abstract][Full Text] [Related]
5. Effects of non-cytotoxic drugs on the growth of multidrug-resistance human gastric carcinoma cell line.
Wang CH; Zheng WB; Qiang O; Tang CW
J Dig Dis; 2009 May; 10(2):91-8. PubMed ID: 19426390
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of octreotide on gastric cancer growth via MAPK pathway.
Wang CH; Tang CW; Liu CL; Tang LP
World J Gastroenterol; 2003 Sep; 9(9):1904-8. PubMed ID: 12970873
[TBL] [Abstract][Full Text] [Related]
7. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells.
Baek MK; Kim MH; Jang HJ; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Oncol Rep; 2008 Dec; 20(6):1569-75. PubMed ID: 19020743
[TBL] [Abstract][Full Text] [Related]
8. Effects of combined octreotide and aspirin on the growth of gastric cancer.
Tang C; Wang C; Tang L
Chin Med J (Engl); 2003 Mar; 116(3):373-7. PubMed ID: 12781040
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
Chun KS; Kim SH; Song YS; Surh YJ
Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
[TBL] [Abstract][Full Text] [Related]
10. Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway.
Kanai M; Konda Y; Nakajima T; Izumi Y; Kanda N; Nanakin A; Kubohara Y; Chiba T
Oncogene; 2003 Jan; 22(4):548-54. PubMed ID: 12555068
[TBL] [Abstract][Full Text] [Related]
11. Effects of retinoic acid on metastasis and its related proteins in gastric cancer cells in vivo and in vitro.
Wu Q; Chen YQ; Chen ZM; Chen F; Su WJ
Acta Pharmacol Sin; 2002 Sep; 23(9):835-41. PubMed ID: 12230954
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro.
Weckbecker G; Liu R; Tolcsvai L; Bruns C
Cancer Res; 1992 Sep; 52(18):4973-8. PubMed ID: 1325289
[TBL] [Abstract][Full Text] [Related]
13. [Effects of inhibition of cyclooxygenase-2 by RNA interference on proliferation and apoptosis of human gastric cancer cells: an experimental study with human gastric cancer cells and mice].
Wang BH; Qian W; Gao YJ; Wang HF; Hou XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):266-71. PubMed ID: 16677508
[TBL] [Abstract][Full Text] [Related]
14. [Effects of combination of octreotide and aspirin on proliferation of human hepatocellular carcinoma].
Tang CW; Tang LP; Wang CH
Ai Zheng; 2002 Apr; 21(4):383-7. PubMed ID: 12452016
[TBL] [Abstract][Full Text] [Related]
15. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1).
Liu TZ; Chen CY; Yiin SJ; Chen CH; Cheng JT; Shih MK; Wang YS; Chern CL
Food Chem Toxicol; 2006 Feb; 44(2):227-35. PubMed ID: 16112786
[TBL] [Abstract][Full Text] [Related]
17. Oxidized LDL induces transcription factor activator protein-1 in rat mesangial cells.
Wu ZL; Wang YC; Zhou Q; Ge YQ; Lan Y
Cell Biochem Funct; 2003 Sep; 21(3):249-56. PubMed ID: 12910478
[TBL] [Abstract][Full Text] [Related]
18. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth.
Liu Y; Ludes-Meyers J; Zhang Y; Munoz-Medellin D; Kim HT; Lu C; Ge G; Schiff R; Hilsenbeck SG; Osborne CK; Brown PH
Oncogene; 2002 Oct; 21(50):7680-9. PubMed ID: 12400010
[TBL] [Abstract][Full Text] [Related]
20. Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent Fra-1 expression.
Ramos-Nino ME; Timblin CR; Mossman BT
Cancer Res; 2002 Nov; 62(21):6065-9. PubMed ID: 12414630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
